Expressions of junB and c-fos are enhanced in 4-nitroquinoline 1-oxide-induced rat tongue cancers

被引:11
作者
Ohyama, M
Hirayama, Y
Tanuma, J
Hirano, M
Semba, I
Shisa, H
Hiai, H
Sugihara, K
Kitano, M
机构
[1] Kagoshima Univ, Sch Dent, Dept Oral Pathol, Kagoshima 8908544, Japan
[2] Kagoshima Univ, Sch Dent, Dept Oral & Maxillofacial Surg 1, Kagoshima 8908544, Japan
[3] Saitama Canc Ctr, Res Inst, Lab Basic Canc Study, Saitama, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan
关键词
4-nitroquinoline 1-oxide (4NQO); c-fos; junB; rat tongue cancer; Tscc1;
D O I
10.1046/j.1440-1827.2003.01587.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Activator protein-1 (AP-1) is a transcription factor activated in many tumors. Using 4-nitroquinoline 1-oxide (4NQO)-induced rat tongue cancers (TC), the present study investigated the expression levels of genes that encode the components of AP-1, the jun gene family (c-jun, junB and junD) and the fos gene family (c-fos, fra-1, fra-2 and fosB). Expression levels of junB and c-fos mRNAs in TC were significantly elevated compared with those in epithelial tissue of control rat tongue, although only c-fos mRNA levels tended to be elevated in dysplastic tongue epithelium. Histologically, all 4NQO-induced rat TC were well-differentiated squamous cell carcinomas. Immunostaining for JunB and c-Fos proteins was positive in the nuclei of tumor cells of all TC. It is noteworthy that JunB was negative, but c-Fos was positive in the dysplastic tongue epithelium of the 4NQO-treated rats. Immunostaining for both proteins was negative in tongue mucosal epithelium of control rats. There were no mutations in the coding regions of either junB or c-fos in all the TC examined. These results suggest the possibility that the expressions of junB and c-fos were enhanced stepwise in 4NQO-induced carcinogenesis of rat tongue, and that the coexpression of JunB and c-Fos might play an important role in the establishment of TC.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 34 条
[1]   Cell cycle promoting activity of JunB through cyclin A activation [J].
Andrecht, S ;
Kolbus, A ;
Hartenstein, B ;
Angel, P ;
Schorpp-Kistner, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) :35961-35968
[2]   Expression pattern of the AP-1 family in endometrial cancer:: correlations with cell cycle regulators [J].
Bamberger, AM ;
Milde-Langosch, K ;
Rössing, E ;
Goemann, C ;
Löning, T .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (09) :545-550
[3]   ABERRANT SUBCELLULAR-LOCALIZATION OF BRCA1 IN BREAST-CANCER [J].
CHEN, YM ;
CHEN, CF ;
RILEY, DJ ;
ALLRED, DC ;
CHEN, PL ;
VONHOFF, D ;
OSBORNE, CK ;
LEE, WH .
SCIENCE, 1995, 270 (5237) :789-791
[4]   JUN-B DIFFERS IN ITS BIOLOGICAL PROPERTIES FROM, AND IS A NEGATIVE REGULATOR OF, C-JUN [J].
CHIU, R ;
ANGEL, P ;
KARIN, M .
CELL, 1989, 59 (06) :979-986
[5]  
Ding W, 2001, J CELL SCI, V114, P1011
[6]   Expression profiles of JunB and c-Fos proteins in the rat circadian system [J].
Edelstein, K ;
Beaulé, C ;
D'Abramo, R ;
Amir, S .
BRAIN RESEARCH, 2000, 870 (1-2) :54-65
[7]   JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes [J].
Finch, JS ;
Joseloff, E ;
Bowden, GT .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (01) :3-10
[8]  
GREENHALGH DA, 1993, CANCER RES, V53, P5071
[9]  
HOLLANDER MC, 1989, CANCER RES, V49, P1687
[10]   Loss of JunB activity enhances stromelysin I expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors [J].
Hulboy, DL ;
Matrisian, LM ;
Crawford, HC .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) :5478-5487